A Different Standard for Ketamine Therapy in Omaha
IV ketamine therapy is not something that should feel rushed, casual, or volume-driven. At Parker Neuroscience, ketamine treatment is delivered as part of a medical psychiatric service line, not as a high-throughput infusion model.
Every patient begins with a clinical evaluation to determine whether IV ketamine is appropriate, safe, and aligned with their psychiatric history. Treatment decisions are based on medical necessity, diagnostic clarity, medication history, and your individual response over time.
Parker Neuroscience was built for patients who need more than another quick prescription change. The goal is not simply to provide an infusion. The goal is to create a carefully monitored treatment pathway for people who have not found adequate relief through traditional approaches.
For patients whose symptoms have not improved after multiple medication trials, learn more about treatment-resistant depression care in Omaha.
What Is IV Ketamine Therapy?
IV ketamine therapy involves the administration of ketamine through an intravenous infusion in a controlled clinical setting. For psychiatric care, ketamine is commonly discussed as an interventional treatment option for patients who have not responded adequately to standard treatments.
At Parker Neuroscience, IV ketamine therapy is individualized. That means treatment is not based on a one-size-fits-all model or a generic infusion schedule. Your care plan is developed around your clinical presentation, treatment history, safety considerations, and response to treatment.
Because ketamine can affect perception, blood pressure, heart rate, and level of awareness during treatment, monitoring is an essential part of care. Parker Neuroscience uses defined protocols and direct clinical oversight throughout the process.
Who May Be a Candidate for IV Ketamine Therapy?
IV ketamine therapy may be considered for adults who have not experienced adequate relief from traditional psychiatric treatments. Many patients who explore ketamine therapy have already tried medications, therapy, lifestyle changes, or other psychiatric interventions without enough improvement.
Patients may seek IV ketamine therapy for concerns such as:
- Treatment-resistant depression
- Major depressive disorder
- PTSD or trauma-related symptoms
- Anxiety symptoms that have not responded to first-line treatment
- OCD symptoms, when clinically appropriate
- Bipolar depression, only after careful evaluation
IV ketamine therapy is not appropriate for everyone. Some medical or psychiatric conditions may require additional screening or may make treatment unsafe. Your consultation is designed to determine whether this treatment is a reasonable and safe option for you.
Patients dealing with trauma-related symptoms can also review Parker Neuroscience’s page on PTSD treatment options in Omaha. Patients primarily struggling with persistent worry, panic, or nervous system overactivation may want to learn more about anxiety treatment in Omaha.
IV Ketamine Therapy vs. Spravato
IV ketamine therapy and Spravato are related but different treatment options.
IV ketamine is administered intravenously and is commonly used in psychiatric care as an off-label interventional treatment. Spravato, also known as esketamine, is an FDA-approved intranasal medication for certain adults with treatment-resistant depression and is administered under a REMS safety program.
The right option depends on your diagnosis, medical history, prior treatment response, insurance considerations, and clinical evaluation. Parker Neuroscience can help determine which pathway may be appropriate for your situation.
Learn more about Spravato treatment in Omaha and how it compares with IV ketamine therapy.
What to Expect at Parker Neuroscience
Your care begins with a thorough consultation. Before IV ketamine therapy is considered, Dr. Parker reviews your psychiatric history, medication history, medical risk factors, and treatment goals. This evaluation helps determine whether ketamine therapy is clinically appropriate and whether another treatment pathway may be a better fit.
If IV ketamine therapy is recommended, your treatment plan is individualized to your needs. Parker Neuroscience uses monitored dosing protocols, advanced safety equipment, and defined discharge standards. Nothing is rushed. Nothing is assumed.
During treatment, you are monitored in a controlled clinical environment. After each session, you must meet discharge criteria before leaving. The experience is designed to support both medical safety and psychological comfort.
This is care with structure: evaluation first, defined protocols throughout, and a personalized maintenance plan calibrated to your response when appropriate.
Why Patients Choose Parker Neuroscience for Ketamine Therapy
Patients searching for ketamine therapy in Omaha are often looking for more than access to a treatment. They are looking for trust, safety, and a clinician who understands complex psychiatric histories.
Parker Neuroscience is designed for patients who want a higher standard of interventional psychiatry care.
Direct Clinical Oversight
Your care is led by Dr. Lisa Parker, DNP, APRN, NP, a doctoral-prepared clinician with more than two decades of experience across emergency medicine and psychiatric care.
Individualized Treatment Protocols
Treatment is calibrated to the individual patient. Dosing, monitoring, treatment planning, and maintenance recommendations are based on clinical evaluation and response, not a generic protocol built for volume.
Continuous Monitoring
IV ketamine therapy requires careful monitoring. Parker Neuroscience uses defined safety standards and continuous clinical observation throughout treatment sessions.
Private, Controlled Treatment Environment
The treatment setting matters. Parker Neuroscience provides care in a private clinical environment designed to support the therapeutic process, not a crowded or chaotic infusion setting.
Integrated Psychiatric Care
Ketamine therapy works best when it fits into a larger treatment plan. Parker Neuroscience can coordinate care with outside therapists, primary care providers, referring clinicians, and primary care medication support when appropriate. Formal psychiatric medication management services are anticipated to begin in early 2027, and Parker Neuroscience is accepting interest from patients seeking a psychiatric medication provider.
For patients who need a broader psychiatric treatment plan, Parker Neuroscience also offers primary care mental health medication support in Omaha.
Conditions Commonly Associated With IV Ketamine Therapy
Patients often explore IV ketamine therapy after years of trying to manage symptoms through traditional psychiatric treatment alone. While every patient is different, IV ketamine therapy may be discussed as part of a treatment plan for several difficult-to-treat psychiatric conditions.
Treatment-Resistant Depression
Treatment-resistant depression generally refers to depression that has not improved enough after standard treatment attempts. For some patients, IV ketamine therapy may be considered after multiple antidepressants, therapy, or other interventions have not provided adequate relief.
Read more about treatment-resistant depression care in Omaha.
PTSD and Trauma-Related Symptoms
PTSD can affect mood, sleep, emotional regulation, relationships, and day-to-day functioning. Some patients with chronic trauma-related symptoms explore interventional psychiatry when conventional treatments have not been enough.
Read more about PTSD treatment options in Omaha.
Anxiety Symptoms
Anxiety can become deeply disruptive, especially when symptoms persist despite medication or therapy. For some patients, anxiety symptoms may be evaluated as part of a broader psychiatric picture when considering interventional treatment.
Read more about anxiety treatment in Omaha.
Safety Comes First
IV ketamine therapy should always be approached as medical care. It is not experiential, recreational, or casual. At Parker Neuroscience, safety is built into the process from the first consultation through each treatment session.
Before treatment begins, Dr. Parker evaluates factors that may affect your eligibility. These may include psychiatric history, cardiovascular risk, blood pressure concerns, substance use history, pregnancy or breastfeeding status, history of psychosis or mania, and other relevant medical considerations.
If IV ketamine therapy is not appropriate, Parker Neuroscience will tell you directly. The goal is not to push every patient into treatment. The goal is to identify the safest and most clinically appropriate path forward.
Cost and Insurance for IV Ketamine Therapy
IV ketamine therapy is not currently covered by most commercial insurance plans and is offered on a transparent private-pay basis. Pricing is discussed directly during your consultation.
Veterans enrolled in the VA Community Care Network may qualify for VA-covered ketamine therapy, depending on eligibility and authorization. Parker Neuroscience can discuss available options during the consultation process.
Spravato may be a more insurance-eligible option for some patients with treatment-resistant depression. During your evaluation, Parker Neuroscience can help clarify which treatment pathway may best fit your clinical and financial situation.
If you are specifically looking for an FDA-approved and insurance-eligible interventional treatment option, learn more about Spravato treatment in Omaha.
IV Ketamine Therapy FAQs
Is IV ketamine therapy FDA-approved for depression?
IV ketamine is commonly discussed in psychiatric care as an off-label treatment option. Ketamine itself is not FDA-approved for the treatment of psychiatric disorders. Spravato, also known as esketamine, is FDA-approved for certain adults with treatment-resistant depression and is administered under a REMS program.
How do I know if I am a candidate for IV ketamine therapy?
Candidacy begins with a clinical evaluation. Dr. Parker reviews your psychiatric history, prior treatment attempts, current medications, medical risk factors, and treatment goals to determine whether IV ketamine therapy is appropriate and safe.
What conditions does Parker Neuroscience evaluate for IV ketamine therapy?
Parker Neuroscience evaluates adults with treatment-resistant depression, PTSD, anxiety, OCD, and related psychiatric concerns. Some patients with bipolar depression may be evaluated carefully to determine whether interventional treatment is appropriate.
Is IV ketamine therapy covered by insurance?
IV ketamine therapy is not currently covered by most commercial insurance plans and is offered on a transparent private-pay basis. Veterans enrolled in the VA Community Care Network may qualify for VA-covered ketamine therapy, depending on eligibility and authorization.
How is IV ketamine different from Spravato?
IV ketamine is administered through an intravenous infusion and is used off-label in psychiatric care. Spravato is an intranasal esketamine medication that is FDA-approved for certain adults with treatment-resistant depression and must be administered in a REMS-certified clinical setting.
Will I be monitored during IV ketamine therapy?
Yes. Parker Neuroscience uses individualized protocols, continuous monitoring, and defined discharge criteria throughout the treatment process. Patient safety is central to every treatment decision.
Do I need a referral for IV ketamine therapy?
Parker Neuroscience welcomes both self-referrals and provider referrals. If you already work with a therapist, psychiatrist, primary care provider, or another clinician, Parker Neuroscience can coordinate care when appropriate.
Start With a Consultation
Ready to talk through your options?
Parker Neuroscience welcomes self-referrals, provider referrals, and general questions from adults exploring advanced psychiatric care in Omaha and throughout Nebraska.
Please do not include medical history, symptoms, medication details, or urgent health concerns in this form.